Forbes article this morning about cloning Seth Klarman's Baupost Capital. The article is entitled "How to Ride Seth Klarman's Coattails" and highlights the performance of Baupost's Top 20 Holdings clone which has returned over 14% annualized since 2000 versus -0.85% annualized for the S&P500TR index. The article also highlights Baupost's current holdings including Biogen Idec [BIIB], Enzon Pharmaceuticals [ENZN] and ViaSat [VSAT].